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Abstract
Background: Traumatic injuries can undermine neurological functions and act as risk factors for the development
of irreversible and fatal neurodegenerative disorders like amyotrophic lateral sclerosis (ALS). In this study, we have
investigated how a mutation of the superoxide dismutase 1 (SOD1) gene, linked to the development of ALS,
modifies the acute response to a gentle mechanical compression of the spinal cord. In a 7-day post-injury time
period, we have performed a comparative ontological analysis of the gene expression profiles of injured spinal
cords obtained from pre-symptomatic rats over-expressing the G93A-SOD1 gene mutation and from wild type
(WT) littermates.
Results: The steady post-injury functional recovery observed in WT rats was accompanied by the early activation at
the epicenter of injury of several growth-promoting signals and by the down-regulation of intermediate
neurofilaments and of genes involved in the regulation of ion currents at the 7 day post-injury time point. The
poor functional recovery observed in G93A-SOD1 transgenic animals was accompanied by the induction of fewer
pro-survival signals, by an early activation of inflammatory markers, of several pro-apoptotic genes involved in
cytochrome-C release and by the persistent up-regulation of the heavy neurofilament subunits and of genes
involved in membrane excitability. These molecular changes occurred along with a pronounced atrophy of spinal
cord motor neurones in the G93A-SOD1 rats compared to WT littermates after compression injury.
Conclusions: In an experimental paradigm of mild mechanical trauma which causes no major tissue damage, the
G93A-SOD1 gene mutation alters the balance between pro-apoptotic and pro-survival molecular signals in the
spinal cord tissue from the pre-symptomatic rat, leading to a premature activation of molecular pathways
implicated in the natural development of ALS.
Background
Mutations of the superoxide dismutase 1 (SOD1) gene
cause degeneration primarily at the level of the spinal
cord motor neurone pool and this detrimental effect
may be accelerated by environmental stressors. SOD1
gene mutations have been found in approximately 20%
of individuals with the inherited form of amyotrophic
lateral sclerosis (ALS) motor neuron disease (MND), a
rapidly progressive and fatal neurological disorder [1].
Neurodegeneration in ALS may result from genetic fac-
tors predisposing motor and glial cells to a higher level
of vulnerability to different types of injuries, like
mechanical stress [2-5]. Retrospective studies have
shown how spondylotic myelopathy, a history of bone
fracture and of surgical treatment are significantly more
represented among ALS individuals compared to the
general population [3]. Likewise, ALS appears to be 5 to
6 folds more prevalent in Italian professional footballers
[3,5]. If mechanical stress plays a part in the unravelling
of ALS as suggested by these epidemiological observa-
tions, it would be important to understand how the
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cascade of stress-induced molecular events precipitates
or simply accelerates the development of ALS in geneti-
cally susceptible individuals.
We have recently shown that a mild compression
spinal cord injury (SCI) and the over-expression of the
G93A-SOD1 gene in the rat can induce the time-depen-
dent transcriptional regulation of the same molecular
responses modulating oxidative stress, apoptosis, inflam-
mation, membrane ion transport and the neurofilaments
homeostasis [6]. These molecular pathways have already
been extensively investigated in these animal models of
spinal cord degeneration [7-14]. The detrimental effect
of neurofilaments aggregation on axonal transport is
widely acknowledged [13], whilst the identification of
motif deletions of the heavy neurofilament subunit gene
[(Nfh); [15]] and of an increase in the levels of Nfh in
the cerebrospinal fluid from ALS patients support the
hypothesis that these cytoskeletal proteins are central in
the pathogenesis of ALS [15,16].
High-penetrance genetic defects like mutations of the
SOD1 gene may not only lead to a neurodegenerative dis-
order but could also increase the nervous tissue suscept-
ibility to trauma in a pre-symptomatic stage. G93A-SOD1
toxicity has already been shown to increase the vulnerabil-
ity of motor neurons and muscles to sciatic nerve injury,
by reducing the post-injury motor unit survival whilst
impairing the muscle contractile characteristics [17].
In this study, we have investigated by large-scale gene
expression analysis how the G93A-SOD1 gene mutation
modifies the acute molecular response to a mild compres-
sion injury in a pre-symptomatic rat. The low-intensity
mechanical stress employed in this study causes no major
tissue damage and healthy rats normally undergo full loco-
motor recovery within a short-time from injury [18,19].
We have also evaluated the post-injury expression profile
of Nfh in the G93A-SOD1 transgenic rats and in their
wild type (WT) littermates, together with the determina-
tion of spare white matter, of macrophage infiltration, of
microglial activation and of the number and size of motor
cells in the spinal cord segment immediately caudal to the
site of injury. In the same one-week post-injury time-
frame, we have compared the recovery of locomotor func-
tions of the G93A-SOD1 rats to the one observed in WT
rats after compression SCI. This study provides further
insight into the toxic effects induced by a SOD1 gene
mutation, showing how the molecular response to a
mechanical trauma can be profoundly modified by this
genetic defect in an otherwise pre-symptomatic rat.
Results
The G93A-SOD1 rats display a poor locomotor recovery
in the first week following mild spinal cord compression
We have previously reported the significant locomotor
improvement that WT animals undergo in a 7 day time-
period following compression spinal cord injury (SCI)
[6]. Prior to surgery, the mean baseline locomotor per-
formances measured using the BBB open-field locomo-
tor rating scale as previously reported [20], were found
not to be significantly different between the G93A-
SOD1 and the WT groups [both above 21; normal pre-
sence of movements]. However, comparative BBB scor-
ing of WT and G93A-SOD1 rats in the 1-week
observation period following compression SCI showed
significant differences (Figure 1). The G93A-SOD1 ani-
mals appear slightly less impaired at 4 hours and at 1
day from compression SCI than their WT littermates,
although this difference was not statistically significant.
The G93A-SOD1 animals show only a marginal
improvement after compression SCI throughout the per-
iod of observation, whilst WT rats display a locomotor
recovery between the first and the second day after
compression SCI, followed by a much higher level of
recovery throughout the 7 day period compared to the
G93A-SOD1 rats (the difference in rated locomotor
functions is statistically significant from the 3rd day, P <
0.05; Figure 1). The BBB scale describes changes in the
articulation of movements of the hip, knee, ankle, tail
and posterior feet position. At the 7 day post-injury
time period, the WT animals achieved a mean BBB
locomotor rating score of 13 which is classified as “...
constant weight support in the plantar step, constant
hindlimbs and forelimbs coordination”. At the 7 day
post-injury time period, the G93A-SOD1 rats achieved a
mean BBB locomotor rating score of 8, which is cate-
gorized as “... frequent or consistent weight support in
the dorsal step and no support in plantar step, soft
movements without supporting the body weight” [20].
The molecular basis of genetic vulnerability of G93A-
SOD1 to trauma was further investigated.
Comparative analysis of the gene expression changes in
G93A-SOD1 and in wild type spinal cords following mild
compression spinal cord injury
We have used an Illumina Bead-chip platform to com-
pare the post-injury gene expression profile in spinal
cord from G93A-SOD1 transgenic rats to the genetically
homogeneous age-matched wild type (WT) littermates
subjected to the same mild compression SCI procedure.
We have pooled spinal cord samples containing the epi-
centers of injury obtained from WT or G93A-SOD1
transgenic rats sacrificed at different time points from
the compression SCI (on average, 5 spinal cord samples
in each pool; see Methods). We have focussed our stu-
dies on the first 7 days after injury, since post-traumatic
cell loss by necrosis and apoptosis involving large ven-
tral horn motor neurones and glial cells is at its highest
levels in this time-window [9]. The data obtained from
the gene expression analysis have been submitted to
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gene expression omnibus (GEO), and can be found in
this repository with the series entry GSE22161 http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22161.
Supplementary files can be retrieved using appropriate
links available from the same database series entry.
The number of differentially regulated genes in injured
WT and G93A-SOD1 spinal cords compared to geneti-
cally-matched uninjured tissues is reported in Figure
2A, for each of the chosen post-injury time-point. At
the 30 minutes, 24 hour and 7 days time points, the
total number of differentially regulated genes after com-
pression injury was higher in WT than in G93A-SOD1
spinal cord. Comparison of down-regulated versus up-
regulated genes (Figure 2B) revealed that the increased
number of differentially regulated genes in the WT
spinal cord at the 7 day time-point compared to G93A-
SOD1 spinal cord was due to down-regulated genes.
The spinal cords from the G93A-SOD1 transgenic rats
showed a larger number of up-regulated genes com-
pared to WT spinal cords at the 4 hour post-injury time
point. Figure 2A and 2B also show that sham surgery in
G93A-SOD1 and WT animals induced the differential
regulation of a number of gene candidates, particularly
in G93A-SOD1 spinal cord at 30 minutes from com-
pression SCI (when compared to genetically and age-
matched naïve animals). The correlation analysis (Bead-
Studio-3 scatter plot) between the WT and the G93A-
SOD1 spinal cord expression profiles after injury and
genetically age-matched naïve tissues corresponds to the
differences seen in the raw number of differentially
regulated genes reported above. Whilst r2 values for the
correlation between SCI and naïve tissues are
Figure 1 Temporal pattern of recovery of locomotor functions after mild compression SCI in the G93A-SOD1 rats and in the WT
littermates. WT animals show a marked functional recovery between 1 and 2 days, followed by a steady locomotor improvement for the
remaining period of observation. WT rats display an improved motor function compared to G93A-SOD1 rats from day 2 to day 7 of the post-
injury experimental period (the difference between the WT and G93A-SOD1 locomotor functions is statistically significant only from the day 3, *
P < 0.05), whereas G93A-SOD1 rats only appeared to perform slightly better, but non-significantly than the WT littermates at 4 hours and at 1
day post-injury. BBB scoring prior to injury of the G93A-SOD1 and the WT rats showed no locomotor dysfunction and no differences in BBB
functional scores between the two genetic types (BBB score >21; normal locomotor functions). Error bars represent SEM. N: 5 animals per group
were used.
Jokic et al. BMC Genomics 2010, 11:633
http://www.biomedcentral.com/1471-2164/11/633
Page 3 of 24
Figure 2 Number of differentially regulated genes at the site of compression spinal cord injury in the G93A-SOD1 rats and in the WT
littermates. A. Graph displaying the total number of differentially regulated genes in the 10 week old WT and G93A-SOD1 spinal cord samples
at the site of compression SCI. The largest difference in the number of differentially expressed gene candidates between the WT and the G93A-
SOD1 spinal cord tissues is seen at the 7-day post-injury time point. B. Break-down of up-regulated versus down-regulated genes in the WT and
G93A-SOD1 spinal cords at different time points from compression injury. The most remarkable difference between the two genetic types is the
down-regulation of 135 genes in WT injured spinal cord tissue at 7 days post-injury, whilst G93A-SOD1 injured tissue down-regulate only 10
genes. Control: naïve and genetically-matched spinal cord samples (from 10 week old pre-symptomatic rats) were used as reference tissues in
the differential gene expression analysis. Five animals per a group were used.
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comparable for G93A-SOD1 and WT spinal cords at 4
hours and 24 hours after injury (4 hours WT, r2: 0.9414;
4 hours G93A-SOD1, r2: 0.9389; 24 hours WT, r2:
0.8588; 24 hours G93A-SOD1, r2: 0.8837), the correla-
tion coefficients diverge significantly at the 7-day time
point, with a r2 of 0.889 for the G93A-SOD1 spinal cord
and a r2 of 0.809 for the WT spinal cord. A lower corre-
lation coefficient indicates a higher level of differential
regulation of the Bead-array 22,418 test-genes in the
spinal cord samples under investigation. The r2 value of
the technical replica experiment performed probing two
separate bead-arrays with the same RNA sample was
0.9876.
We have used High Throughput GO-Miner as pre-
viously reported [6,21] to obtain an integrated ontologi-
cal analysis of the gene expression datasets of injured
G93A-SOD1 and WT spinal cords. This program identi-
fies gene categories within the Gene Ontology (GO)
database that are enriched with the differentially
regulated genes under investigation and display a signifi-
cant false discovery rate (FDR < 0.05), a value which
indicates the statistical significance of the identified
gene category by eliminating probe signals detected only
by chance [21]. Of the 150 gene categories computed by
High Throughput GO-Miner, 36 with a broad biological
significance and not related to any specific functional or
biological mechanism (e.g. GO:0007610_behavior;
GO:0019725_cell_homeostasis; GO:0009893_positive_
regulation_of_metabolic_process; GO:0042592_homeos-
tatic_process) were excluded from further analysis, as
were 66 gene categories showing the same temporal dis-
tribution and level of FDR significance in G93A-SOD1
and in WT spinal cord. The time dependent expression
of the remaining 48 gene categories has been graphically
displayed in a heat-chart, where the FDR value for each
gene category at a specific time point is represented
with a colour-code (Figure 3). The selected gene cate-
gories are grouped into functional headings, according
to their “parent-child” relationship and biological affi-
nity. Gene categories found to be up-regulated in
G93A-SOD1 spinal cord, those up-regulated in WT
spinal cord, those down-regulated in G93A-SOD1 and
those down-regulated in WT spinal cord are reported in
Figure 3A, B, C and 3D respectively. Those gene cate-
gories up-regulated predominantly in G93A-SOD1
spinal cord seem to be mostly detected at 4 hours post-
injury (Figure 2A), whereas those differentially regulated
in WT spinal cord are identifiable mainly at the 24 hour
and 7 day time points (Figure 3B, D). The key changes
shown in Figure 3 will now be briefly reviewed:
The 30 min time point
Only four gene categories are differentially regulated at
the 30 minutes post-injury time point, all of which are
up-regulated in the G93A-SOD1 spinal cord and mainly
involved in transcriptional mechanisms and in cell
motility.
The 4 hour time point
Among those gene categories activated only in G93A-
SOD1 spinal cord at this time point, some supervise the
development of neuronal and myeloid cells, the differen-
tiation of lymphoid organs and the regulation of the
synaptic plasticity (Figure 3A). At this time point, gene
candidates with a pro-apoptotic effect and involved in
the release of cytochrome C from mitochondria, become
significantly up-regulated in G93A-SOD1 spinal cord,
together with other genes involved in macrophage
migration, in the interleukin-6 and TNF-alpha molecular
cascades and in the regulation of T-cell proliferation and
cytokine production. The only gene category selectively
regulated in WT spinal cord at the 4 hour time-point
contains gene candidates involved in angiogenesis
(GO:0001525; Figure 3B).
The 24 hour time point
As previously reported [6], WT spinal cord presents, at
this post-injury time point, gene expression changes
with a likely pro-survival effect, such as the up-regula-
tion of genes involved in lipid transport (Figure 3B).
Other molecular responses that may be detrimental to
spinal cord functional recovery are also prominent,
including the activation of macrophage and interleukin-
6 molecular pathways (Figure 3B). Unlike G93A-SOD1
spinal cord tissue, WT spinal cord up-regulates gene
candidates involved in cell cycle control as previously
reported in a rat model of mild spinal cord injury [8,22].
The 7 day time point
This time-point is characterised by further up-regulation
of pro-survival signals in WT spinal cord, including
gene candidates involved in cell adhesion and in the for-
mation of the extra-cellular matrix. As reported above,
the 7-day time-point after compression SCI displays the
most remarkable difference between G93A-SOD1 and
WT spinal cord in the post-injury period in study
(Figure 2A, B). This is represented by the down-regula-
tion only in WT spinal cord of 135 genes (Figure 2B),
which are part of 9 gene categories according to our
High Throughput GO-Miner analysis (Figure 3D). These
down-regulated genes supervise the homeostasis of
intermediate neurofilaments, cholesterol and isoprenoid
metabolism, striated muscle contraction, ion and neuro-
transmitter transport, and cell-cell signalling.
More detailed analysis of the Bead-array results indi-
cates that the genes included in the intermediate neuro-
filaments GO category (GO:0045104), and particularly
the neurofilament heavy chain (Nfh), show a significant
drop in expression in WT spinal cord at 7 days from
injury, whilst its expression transiently increases
between 4 and 24 hours from compression SCI (Figure
3D; 4A). G93A-SOD1 spinal cord shows a similar
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Figure 3 Comparative gene expression analysis by High-Throughput GoMiner of spinal cord samples from G93A-SOD1 and WT rats
subjected to a mild compression SCI. The heat chart displays the Gene ontology (GO) categories (grouped into main functional headings)
computed by High Throughput GoMiner computational analysis of the differentially expressed genes identified in spinal cord from WT and G93A-
SOD1 rats after compression SCI, using naive (10 week old) spinal cord tissue from rats of the same genetic type as reference. High Throughput
GoMiner defines the biological significance of the gene expression changes according to a multilayered process of statistical processing. GO
categories are selected on the basis of their high level of enrichment of the differentially expressed genes, using a false discovery rate correction
(FDR) cut off of <0.05. FDR introduces a multiple comparisons correction, allowing the exclusion of those gene categories that would appear
enriched simply by chance. Functionally similar GO categories are grouped within the same heading and reported as up-regulated predominantly
in G93A-SOD1 spinal cord (A, ↑G93A-SOD1), in WT spinal cord (B. ↑WT), down-regulated in G93A-SOD1 spinal cord (C. ↓G93A-SOD1) and in WT
spinal cord (D. ↓WT). The various levels of significance of differential regulation for each gene category are represented in the heat-chart with
different colour codes (the correlation between colour codes and FDR values is reported at the bottom of the heat-chart). G93A-SOD1/WT column:
Comparison between the gene expression profiles of spinal cord samples from G93A-SOD1 and WT naïve rats (10 week of age).
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Figure 4 Differential regulation in injured spinal cord tissue from WT and G93A-SOD1 rats of the intermediate neurofilament heavy
chain and of genes involved in retinol metabolism according to Bead-array analysis. A. Profile of post-injury differential expression of the
neurofilament heavy chain (Nfh) in the WT and in the G93A-SOD1 spinal cords (intermediate neurofilaments gene category, GO:0045104),
according to the Bead-array gene expression analysis. Note the higher level of expression of the neurofilament in G93A-SOD1 spinal cord at all
the post-injury time points and its significant level of down-regulation in WT spinal cord at 7 days from injury compared to naive tissue. B. The
graph reports the 7 day post-injury up-regulation in WT and G93A-SOD1 injured spinal cord of genes included in the retinol metabolism gene
category (GO:0042572), including retinol binding protein 1 (RBP1) and cellular retinoic acid binding protein 2 (CRABP2). The up-regulation is
expressed as the ratio of intensities between injured and naive tissues. Two additional genes within the GO:0042572 gene category, the alcohol
dehydrogenase 1 (ADH1) and aldehyde dehydrogenase 1, member A2 (ALDH1a2) are up-regulated only in the G93A-SOD1 spinal cord at 7 days
from injury.
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pattern of temporal expression change for Nfh, but this
intermediate neurofilament maintains a higher level of
expression compared to WT spinal cord and no signifi-
cant drop in expression between 24 hours and 7 days
(Figure 4A; FDR < 0.05). The SCI-induced differential
regulation of Nfh has been further characterised by real-
time RT-PCR and immunohistochemistry as reported
below. Another relevant feature of the post-injury spinal
cord molecular profile at the 7-day time-point is the up-
regulation of a gene category involved in retinoid meta-
bolism (GO:0042572; Figure 3A, B). This gene category
contains 34 genes which control retinol metabolism and
the homeostasis of vitamin A, 12 of which are reported
in the Bead-array utilized in this study. The post-injury
up-regulation of GO:0042572 is shown in both spinal
cord genetic types in this study, (Figure 3A, B) at 7 days
post-injury, with a higher level of statistical significance
for the G93A-SOD1 spinal cord (FDR:0.003) compared
to WT spinal cord (FDR:0.04). Our Bead-array analysis
shows that retinol binding protein 1 (RBP1) and cellular
retinoic acid binding protein 2 (CRABP2) display a sig-
nificant level of up-regulation at 7 days compared to
naïve and genetically matched spinal cord tissue in both
WT and G93A-SOD1 spinal cord, whilst only G93A-
SOD1 spinal cord shows up-regulation of Alcohol dehy-
drogenase 1 (ADH1) and of Aldehyde dehydrogenase 1,
member A2 (ALDH1a2) (Figure 4B).
Gene expression changes after laminectomy
Our gene expression study indicates that sham-
operation induces the differential regulation of a smaller
number of genes in the spinal cord at both the 30 min-
utes and at the 4 hours post-injury time points, when
compared to the amount of gene expression changes
generated by mild compression SCI (Figure 2A, B). High
Throughput Go-Miner computation of the gene expres-
sion changes induced by laminectomy in these spinal
cord tissues at the 30 minutes and at the 4 hours post-
injury time points has disclosed a total of 126 gene cate-
gories. Like for the compression SCI experiment, 33
general gene categories were excluded from further ana-
lysis, whilst 60 gene categories appeared to have the
same pattern of expression and level of significance in
G93A-SOD1 and in WT spinal cord. Figure 5 shows the
remaining 33 gene categories with a FDR < 0.05 in
either G93A-SOD1 or WT spinal cord, at 30 minutes
and 4 hours from laminectomy. Most of the differen-
tially expressed gene categories are up-regulated in the
G93A-SOD1 spinal cord, 4 hours after laminectomy.
The genes included in these categories encompass a
wide range of functional processes including nitric oxide
metabolism, cell adhesion, ion homeostasis, transcrip-
tion, apoptosis, mitochondrion organization and biogen-
esis, and interleukin-6 biosynthesis (Figure 5A). Eight
gene categories containing a wide range of genes related
to the muscle cytoskeletal structure (e.g. myofibril, sar-
comere, troponin complex, actin filaments, muscle con-
traction machinery) are significantly down-regulated
only in WT spinal cord 30 minutes after laminectomy
(Figure 5).
Direct comparison of G93A-SOD1 vs WT spinal cord tissue
Using BeadStudio-3, we have been able to directly com-
pare the expression profiles of G93A-SOD1 and WT
spinal cord tissues harvested at the selected time-points
after compression SCI. We have identified 33 gene can-
didates with a significant level of differential regulation.
Further evaluation of the nature of the differential regu-
lation of these gene candidates in each tissue type was
performed using genetically and age-matched naïve tis-
sue as reference. The differentially regulated genes are
reported in Figure 6, along with their reference GO
categories. In each tissue type, genes are reported as up-
regulated or down-regulated (compared to genetically-
matched naïve tissue). In bold are those genes whose
expression changes in both the WT and the G93A-
SOD1 spinal cord, and those gene categories that have
been selected by the High Throughput GO-Miner analy-
sis (reported in Figure 3) and that contain these differ-
entially regulated genes.
At 7 days after injury, the hyperpolarization-activated
cyclic nucleotide-gated potassium channel 2 (Hcn2)
appears to have one of the highest levels of differential
regulation when directly comparing G93A-SOD1 to WT
injured tissues. This is the result of its up-regulation in
G93A-SOD1 spinal cord and of its remarkable down-
regulation in WT spinal cord (Figure 6). Hcn2 is repre-
sented in a number of “parent-child” gene categories
according to the GO database, which contain function-
ally related gene candidates involved in cell-cell signal-
ling (GO:0019226) and ion transport (GO: 0006813).
Other genes involved in membrane ion exchange and
synaptic transmission show the same temporal pattern
of down-regulation in WT spinal cord (though remain-
ing unchanged in G93A-SOD1 spinal cord), including
the voltage-gated sodium channel type IV beta subunit
(SCN4B) and the ATPase Ca(2+) transporting plasma
membrane 3 (Atp2b3; Figure 6). The same pattern of
over-expression in G93A-SOD1 spinal cord and of
down-regulation in WT spinal cord has been identified
for the microtubule-associated protein B 1 (Mapb1) at
24 hours and for the microtubule-associated serine/
threonine kinase family 1 (Mast1) at 7 days from com-
pression SCI (Figure 6). Mapb1 has been reported to
bind to microtubules promoting their stabilization
within axons, and to facilitate the interplay between the
microtubule system and microfilaments. Microtubules
play a dominant role in the central growth cone and are
essential for the maintenance and the elongation of the
axon. Mast1 becomes up-regulated in the G93A-SOD1
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Figure 5 High throughput GoMiner ontological analysis of the differentially regulated genes in WT and G93A-SOD1 spinal cord at 30
minutes and 4 hours after laminectomy. The heat chart displays headings containing clusters of functionally related Gene ontology (GO)
categories, computed using High Throughput GoMiner. Those gene categories found to be up-regulated in WT and G93A-SOD1 spinal cord tissue
after laminectomy compared to naive and genetically matched spinal cord tissues are displayed in Figure 5A, whilst the gene categories which
become down-regulated are reported in Figure 5B. At 4 hours from laminectomy, a large number of gene categories are over-expressed only in
G93A-SOD1 spinal cord. At the 30 minutes time point, WT spinal cord gene expression differs from G93A-SOD1 tissue for the down-regulation of
a number of cytoskeletal gene categories. 10 week old genetically age-matched spinal cord tissues were used as reference. Other: categories
which include genes involved in the regulation of the action potential, of the DNA damage response and of signal transduction.
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Figure 6 Gene candidates showing a significant differential regulation comparing the G93A-SOD1 to the WT spinal cord after mild
compression SCI. 31 gene candidates have been found to have a significant level of differential expression comparing G93A-SOD1 and WT
naïve spinal cord tissues at 10 weeks of age (*) and the same tissues at different time points after mild compression SCI (Bead-array analysis).
Each gene’s differential regulation is further characterised by comparing the injured spinal cord tissue with genetically-matched naive spinal cord
tissue and reported as fold changes of the ratio injured/naïve tissues. The genes are sub-divided according to whether their expression change
occurs in WT spinal cord, in G93A-SOD1 spinal cord or in both (genes reported in bold) and to whether their expression increases (↑) or
decreases (↓) compared to naïve genetically-matched spinal cord tissues. The majority of genes showing differential expression after SCI are
identified in the 24 hours and in the 7 days time points. Mapb1, Hcn2 and Mast1 (reported in bold) are differentially regulated in both WT and
G93A-SOD1 spinal cords and the differential regulation seems to go in the opposite way for each gene candidate in the two tissues in study
when genetically age-matched naive tissue is used as reference. The GO categories which include the differentially regulated genes are also
reported (in bold those already identified by GoMiner ontological analysis, Figure 2). *: Nfh expression appears to decrease significantly in the WT
spinal cord at 24 hours and 7 days from compression SCI, compared to age-matched and genetically-matched naïve spinal cord.
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spinal cord at 7 days from injury, whilst its expression
diminishes in WT tissue at the same post-injury time
point. MAST1 is part of the cell’s scaffolding kinase
activity, with a selective expression in oligodendrocytes
and in white matter containing brain regions. Among
cytoskeletal gene candidates that behave differently in
the two genetic types of injured spinal cord, we have
identified the myelin protein zero (mpz, P0) and Nfh.
Mpz, an important constituent of the myelin sheet,
undergoes a significant up-regulation in injured G93A-
SOD1 tissue a 7 days from compression SCI, whilst the
differential regulation of Nfh (GO:0045104) at 24 hours
and at 7 days post-injury, is the result of a significant
down-regulation only in WT spinal cord (Figures 3D, 6).
Among those genes undergoing a selective up-regula-
tion in the G93A-SOD1 spinal cord and remaining
unchanged in the WT tissue (Figure 6), we have identi-
fied alpha 1 defensin (Defa) and the tissue inhibitor of
metalloproteinase 2 (Timp2). Defa is known to have
antimicrobial properties and to be localised in the gran-
ules of neutrophils from where it can be secreted.
Timp2 belongs to a group of matrix inhibitors of metal-
loproteinases, whose potential tissue repair-promoting
effect has been recently exploited as a therapeutic target
in acute brain injuries [23]. Furthermore S100A8 and
calcium binding protein 7 (Capb7), both up-regulated in
the G93A-SOD1 spinal cord, are predominantly
expressed in glial cells.
As previously reported [6], among those gene candi-
dates down-regulated in the G93A-SOD1 uninjured
spinal cord (10 weeks of age), we have identified constitu-
ents of collagen, components of the muscle contractile
machinery like the human troponin I fast-twitch isoform
2 and 3 (Tnni2/3) genes, the myosin light chain 2 and 6
(Myl2; Myl6), the actin - alpha skeletal muscle 1 (Acta1),
the actinin – alpha 3 (Actn3), and the creatine kinase –
muscle type (Ckm; GO: 0006941; Figures 3C, 6). The
mitochondrial ribosomal protein L18 (Mrpl18) is also
down-regulated in the G93A-SOD1 spinal cord at 4
hours and 7 days from compression SCI.
Real-time RT-PCR
we have used real-time RT-PCR to confirm the differen-
tial regulation of Hcn2, Nfh, Timp2, S100A8 and Map1b,
previously shown by Bead-array analysis. Figure 7 shows
how both real-time RT-PCR and Bead-array analysis dis-
play a significant up-regulation in G93A-SOD1 spinal
cord of the selected gene candidates, although the degree
of differential regulation varies between the two techni-
ques. Map1b differential regulation at 24 hours from
injury, as demonstrated using real-time RT-PCR and
Bead-array analysis, results from its up-regulation in
G93A-SOD1 spinal cord and from its down-regulation in
WT spinal cord (Figures 6, 7). The high G93A-SOD1 to
WT Nfh expression ratio at 24 hours (and to a lesser
extend at 7 days from injury) is the result of a significant
down-regulation of this gene in WT injured spinal cord
as already reported (Figures 6, 7).
Expression of Nfh and of synaptophysin
To confirm that the spinal cord regulation of Nfh
expression varies between WT and G93A-SOD1 animals
at different time-points from injury (as shown using
direct differential gene expression analysis by Bead-array
and real-time RT-PCR, Figures 6, 7) we have carried out
immunostaining for Nfh in comparable sections of
spinal cord caudal to the epicenter of compression SCI,
from WT and G93A-SOD1 rats (Figure 8A-B). Nfh
expression by immunostaining appeared tendentially
higher in the G93A-SOD1 spinal cord at all the post-
injury time points considered when compared to the
WT spinal cord, although only the 24 hour time point
displayed a statistically significant difference (Figure 8E;
p < 0.03). This significant difference in Nfh protein
expression levels between the two groups at 24 h post-
injury was further confirmed using Western blotting
(Figure 8G-H).
We have also performed immunostaining of the similar
sections for synaptophysin (SYN), a membrane glycopro-
tein of the pre-synaptic vesicles in neuron, whose expres-
sion does not seem to be altered following compression
SCI according to our gene expression analysis
(Figure 8C-D). Both Nfh and SYN have already been
described to become differentially regulated in neurologi-
cal structures subjected to mechanical injury [24,23]. SYN
immunostaining shows selective staining of synaptic bou-
tons, with no statistically significant difference between
WT and G93A-SOD1 tissues of the protein expression of
this gene at the post-injury time points considered
(Figure 8F). In addition, the staining does not reveal any
significant difference in SYN regional distribution in the
G93A-SOD1 compared to the WT spinal cord. Both these
proteins have been previously demonstrated to become
differentially regulated in neurological structures subjected
to mechanical injury [24,25].
Histopathological assessment of the acute effects of mild
compression spinal cord injury
We have used a luxol fast blue staining to examine
spared spinal cord white matter following compression.
The white matter appears to be mostly intact in the
spinal cord segment caudal to the compression site (Fig-
ure 9). The comparison between the WT and the
G93A-SOD1 rats showed that the area of spared white
matter was not significantly different between the two
groups (P = 0.30). Previous studies have identified
increases in ED1 immunopositive macrophage infiltra-
tion, OX42 immunopositive activated microglia and
GFAP immunopositive astrocytes in the spinal cord
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following injury [26,27]. At 7 days after spinal cord
compression in the WT and in the G93A-SOD1 rats,
there was an increase in the number of ED1-, OX42-
and GFAP- immunopositive cells in the spinal cord cau-
dal to the compression site (Figure 10-11. However, no
significant difference was observed between the WT and
the G93A-SOD1 rats (ED1, P = 0.08; OX42, P = 0.76;
GFAP, P = 0.31).
Reduced motor neurones size in the G93A-SOD1 spinal
cord following compression spinal cord injury
To examine motor neurones, Nissl staining was used
since the motor neurone marker choline acetyltransferase
has been shown to be significantly reduced following
spinal cord injury [28]. Motor neurone morphology can
be clearly seen in the ventral horn of a spinal cord region
caudal to the injury epicenter 7 days after mild compres-
sion SCI (Figure 11A-F). At this post-injury time point,
the number of motor neurones in the ventral part of the
spinal cord of WT rats did not differ from the number of
motor neurones in the G93A-SOD1 rats (Figure 11H).
However, motor neurones in the anterior horns from the
G93A-SOD1 rats were significantly smaller in soma size
(Kolmogorov-Smirnov test, p < 0.05) compared to those
from WT littermates (Figure 11I).
Discussion
This study shows how the over-expression of the G93A-
SOD1 gene mutation modifies the molecular response to
a mild mechanical compression in the spinal cord tissue
from a pre-symptomatic rat. Using a histopathological
assessment of the compression injury, we have found no
significant differences between the WT and the G93A-
SOD1 animals in the post-injury immunoresponse or in
the amount of spared white matter following the trauma
(Figures 10-11). Hence, despite delivering comparable
spinal cord compression injuries to pre-symptomatic WT
and G93A-SOD1 rats, G93A-SOD1 rats displayed a sig-
nificantly lower level of post-injury locomotor recovery
than their WT littermates. We observe that the
Figure 7 Histogram representing the G93A-SOD1 versus WT ratios of the spinal cord intensity values detected for Nfh, Map1b,
S100A8, Timp2 and Hcn2 at 24 hours and at 7 days from compression injury, as measured by Bead-array and real-time RT-PCR
analysis. The G93A-SOD1 vs WT expression ratios obtained using Bead-array (red code) and real time RT-PCR (blue code) analyses for Nfh,
Map1b, S100A8, Timp2 and Hcn2 at two time points after compression SCI are reported. The two techniques of gene expression analysis confirm
independently the same type of differential regulation for the selected gene candidates. S100A8 real-time RT-PCR confirms both the significant
up-regulation in the G93A-SOD1 spinal cord detected by Bead-array analysis 7 days from compression SCI. Map1b RT-PCR has been included in
order to validate the sensitivity of the real time RT-PCR and Bead array analyses for expression changes close to two-folds.
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Figure 8 Expression of neurofilament heavy chain and synaptophysin in ventral spinal cord at 24 hours after compression SCI.
Neurofilament heavy chain (Nfh; clone N52) staining of spinal cord sections is clearly visible in motor neurons (arrows) and adjacent axons in
both WT (A) and G93A-SOD1 (B) which is significantly stronger in the G93A-SOD1 (* P = 0.03; E). Scale bar = 100 μm. Transverse sections are
taken within a segment 10 mm caudal to the injury epicenter. Synaptophysin (SYN) immunoreactive synaptic boutons (arrows) can be seen
surrounding unstained motor neuron cell bodies in both WT (C) and G93A-SOD1 (D) spinal cord, with no difference in SYN distribution between
the two genetic types. The intensity of staining is non-significantly different between the G93A-SOD1 and wild type spinal cords (F). Scale bar =
25 μm. SCI-SOD1: spinal cord tissue from rats over-expressing the G93A-SOD1 gene mutation. SCI-WT: spinal cord tissue from WT rats. Western
blot of spinal cord rostral to the injury epicenter obtained from WT and G93A-SOD1 rats. Three spinal cord samples for both WT and G93A-SOD1
were used (G). A significant increase in Nfh (clone 52) expression levels can be detected in G93A-SOD1 rats compared to WT rats with b-actin as
the internal control (* P = 0.041; H).
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significant differences in the post-injury locomotor recov-
ery between the WT and the G93A-SOD1 rats are not
due to differences in the induction of the injury, but
rather to an intrinsically different molecular response to
trauma in the two genetic variants of rats. A significantly
low level of functional recovery has also been reported in
G93A-SOD1 transgenic mice after sciatic nerve injury,
with an acceleration of the disease progression so that 90
day old mice show deficits that are normally only seen at
the end stage in uninjured G93A-SOD1 mice [17].
Whilst mutations of the SOD1 gene account only for
approximately 2% of the whole ALS population, other
not yet identified predisposing or causative genetic fac-
tors may act along the same lines, reducing the neurore-
generative potential and escalating the level of disability
after trauma. These observations may partially explain
the observed higher occurrence of ALS cases among
individuals that have been exposed to repetitive
mechanical trauma or that have been subjected to other
forms of mechanical stress or surgical procedures
[2,3,5].
For the purpose of our study, we have employed a well-
characterised experimental platform of mechanical stress,
which is known to cause only a mild damage to the spinal
cord and to be associated with a good outcome in terms
of post-traumatic locomotor recovery in rodents
[29,19,30]. Other forms of injury cause a significant level
of tissue destruction and a more florid profile of gene
expression changes, masking subtle transcriptional
changes that may be induced by the SOD1 gene mutation
in an otherwise macroscopically healthy spinal cord.
Under the experimental conditions of mild SCI, the
G93A-SOD1 spinal cord displays a higher number of up-
regulated genes compared to WT tissue at the 4 hour
post-injury time point (Figure 2A-B). These include a
broad range of genes involved in the modulation of
macrophages, Toll-response, T and B-cell proliferation
and in the production of interleukin-6 and TNF-alpha,
featuring an early inflammatory response that surfaces
only at a later time point in WT spinal cord (Figure
3A-B). Other gene expression changes unique to the
G93A-SOD1 animal are detected in two later time
points within the experimental period. Following the
4-hour time point, the G93A-SOD1 spinal cord displays
characteristic apoptotic signals, like the activation of
genes regulating cytochrome C release from the mito-
chondria. Cytochrome C release is known to occur
when the inner mitochondrial membrane becomes
excessively permeable to ions, leading to energy failure
and apoptosis [31,12]. The inflammatory milieu and the
activation of cell-death signals in the spinal cord at this
stage of the animal recovery may reduce the tissue
repair potential contributing to the observed poor func-
tional recovery observed in the G93A-SOD1 rat.
The post-injury molecular profile of the G93A-SOD1
spinal cord does not show the down-regulation of a
large number of genes 7 days from compression SCI
demonstrated in WT rats compared to naïve controls
(Figures 2A-B; 3D). For example, those genes that
control cholesterol and isoprenoid biosynthesis remain
up-regulated in the G93A-SOD1 spinal cord at this
Figure 9 Spared white matter in spinal cord caudal to
compression epicenter. Spared white matter stained with luxol
fast blue can be seen clearly in WT (A) and G93A-SOD1 (B) in
sections caudal to the compression epicenter 7 days after
compression SCI. Morphometric analysis of the cross sectional areas
of luxol fast blue stained white matter in WT and G93A-SOD1
showed no significant difference between groups (P = 0.30, C). ns =
non-significant. Scale bar = 200 μm.
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Figure 10 Immunoresponse in spinal cord caudal to compression epicenter. ED1 immunopositive cells (macrophages) were detected in
the spinal cord ventral horn of WT (A) and G93A-SOD1 (B) in sections caudal to compression epicenter 7 days post-injury. Quantification
showed an elevated but non-significant increase in ED1 immunopositive cells in G93A-SOD1 compared to WT spinal cord (P = 0.08, C). OX42
immunopositive cells (activated microglia) were detected in the spinal cord ventral horn of WT (D) and G93A-SOD1 (E) in sections caudal to
compression epicenter 7 days post-injury. Quantification showed no significant difference in OX42 immunopositive cells in spinal cord of both
groups (P = 0.76, F). ns: non-significant. Scale bar = 200 μm.
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time-point after compression injury. Isoprenoids are bio-
logical precursors of carotenes and of coenzyme-Q, reti-
nol and tocopherol (vitamin E), compounds known to
modulate mitochondrial activity and oxidative stress
[32,33]. A previous report has documented a state of
systemic dyslipidemia in individuals with ALS and this
state of altered lipid homeostasis has been linked to a
potential neuroprotective effect [34]. The presence of a
SOD1 gene mutation or of a genetic predisposition to
develop ALS may be associated to a state of dysregula-
tion of molecular pathways of cholesterol and isoprenoid
biosynthesis, both during the natural development of the
Figure 11 Changes affecting astrocytes and motor neurones in spinal cord caudal to the compression epicentre. GFAP immunopositive
cells (astrocytes) were detected in the spinal cord ventral horns of the WT (A) and of the G93A-SOD1 (D) rats, in sections caudal to the
compression epicenter 7 days post-injury. Quantification showed an elevated but non-significant increase in GFAP immunopositive cells in the
G93A-SOD1 compared to the WT spinal cord (P = 0.31, G). Large Nissl stained cells (motor neurones) were detected in the spinal cord ventral
horn of WT (B-C) and of G93A-SOD1 (E-F) in sections caudal to the compression epicenter 7 days post-injury. Although the number of motor
neurones in the ventral horns are not significantly different between the two groups, further analysis of the motor cells soma size showed that
the motor neurones in the WT spinal cord were larger than those identified in the G93A-SOD1 spinal cord (H-I). Kolmogorov-Smirnov test
revealed a significant leftward shift in motor neurone soma size of the G93A-SOD1 spinal cord compared to WT spinal cord (P < 0.05, I). ns: non-
significant. Scale bar = 200 μm.
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disease and in response to a stressful situation like a
mechanical injury.
Also down-regulated in WT spinal cord at the 7-day
post-injury time point are many genes that like Hcn2
control cell-cell signalling and ion/neurotransmitter
transport (GO:0019226; GO:0006836, Figures 3D and 6).
Previous experimental observations in animal models of
ALS and brain ischemia have reported increased neuro-
nal excitability in affected tissues, generated by the up-
regulation of genes capable of modulating ion currents
[3,13]. Hence, the acquisition of a state of tissue hyper-
excitability may represent a distinguishing feature of
SOD1-induced ALS, both during the natural develop-
ment of the disease and also in a pre-symptomatic
phase as a result of a stressful condition.
At the 7 day time-point, both the WT and the G93A-
SOD1 spinal cords up-regulate genes involved in retinol
(vitamin A) metabolism including RBP1 and CRABP2,
whilst only the G93A-SOD1 spinal cord tissue presents
the additional up-regulation of ADH1 and ALDH1 (Fig-
ure 4B). A link between the vitamin-A down-stream
effects and the pathological changes observed in ALS
has already been suggested [35-38]. Early vitamin-A
deprivation, for example, causes motor cell loss in
rodents [35]. RBP1 and CRABP2 are over-expressed in
spinal cord from the end-stage G93A-SOD1 rat, whilst
surviving small motor neurons show selective immunos-
taining for specific retinoid receptors [36-38]. Our
observations in the acute post-injury phase may inspire
potential neuroprotective therapeutic strategies, since
both the alteration of ion current regulation and the
activation of retinoid signalling can be pharmacologically
modified.
We and others have already reported the post-injury
down-regulation and/or accumulation of phosphorylated
and non-phosphorylated neurofilaments and of synapto-
physins (SYN), the latter appearing to be linked to post-
traumatic motor and cognitive deficits in different mod-
els of neurotrauma [24,25,6,39]. Given the reported
trauma-induced differential regulation of Nfh and SYN
expression along the motor cell/axon/synapsis axis, we
have evaluated the Nfh and SYN differential regulation
in our injury model. At a RNA level, Nfh expression
appears to be higher in injured G93A-SOD1 spinal cord
compared to injured WT tissue from the 4 hour time
point onward (Figure 4A). Post-injury protein expression
of Nfh measured by immunohistochemistry is also ten-
dentially higher in the G93A-SOD1 spinal cord at all
the time points, with a significant level of differential
expression at the 24 hour time-point, which was further
confirmed with Western blotting (Figures 4, 5, 6, 7, 8).
This observation may indicate that neurofilaments
expression is altered in a situation of genetic susceptibil-
ity to develop ALS, both under conditions of stress and
during the natural development of the disease. Inter-
mediate neurofilaments like peripherin within spheroid-
like structures are already known to accumulate in
affected tissues from animal models of ALS and to pos-
sibly interfere with axonal transport [13]. We did not
observe any significant differential regulation or any
genotype-specific redistribution of SYN in spinal cord
after compression SCI. Failure to detect a post-injury
change in SYN expression or re-distribution in our
study may be related to the relatively low force of
impact or to the fact that changes in synaptic vesicle
transportation as a consequence of a mild compression
SCI may have not yet occurred in its full scale in the 7-
day time period. Another indication that SOD1 gene
defects may act on the homeostasis of neurofilaments
when nervous tissue is under stress is the up-regulation
of Mapb1 and possibly of Mast1 in the post-injury
G93A-SOD1 spinal cord, both genes appearing to be
down-regulated in WT spinal cord after compression
injury (Figure 6). Mapb1 binds to microfilaments linking
them with the microtubule system, whilst remaining
associated to the plasma membranes. Mapb1 exerts a
central role in the process of axonal elongation and
branching [40]. The observed selective activation of
Map1b in G93A-SOD1 spinal cord could be part of a
compensative neuroprotective response that counters
the intrinsic SOD1-mediated vulnerability under condi-
tions of stress. This survival program may be mediated
by the activation of molecules involved in the mainte-
nance of the cytoskeletal integrity as well as by the pro-
duction of cholesterol and isoprenoids derivates as
reported above.
Microarray studies in spinal cord have shown that
sham operation alone can induce gene expression
changes similar to those caused by mild injury, but only
in the first few hours after trauma [8,22]. Our study
confirms that simple laminectomy triggers the transcrip-
tional regulation of a wide range of gene categories in
both the WT and the G93A-SOD1 spinal cords. How-
ever, gene categories involved in transcription, differen-
tiation, ion homeostasis, apoptosis, organisation of
mitochondrial function and interleukin-6 release become
activated only in the G93A-SOD1 spinal cord at 4 hours
from laminectomy. It is clear from our experiments that
both laminectomy and mild spinal cord injury provoke a
mixture of pro-survival and pro-apoptotic expression
changes, the latter being dominated by mitochondrial
cell-death signals and interleukin-6-mediated inflamma-
tory changes.
In this study, we have attempted to correlate the poor
functional recovery observed in the G93A-SOD1 rats
during the acute post-injury phase with changes at the
level of individual cell types in the affected spinal cord.
We have shown only a trend towards an increase in
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microglia, macrophages and astrocytes in a cord seg-
ment caudal to the injury epicenter in the G93A-SOD1
spinal cord compared to WT littermates under the same
experimental conditions, but no significant changes in
the number of these cells between the two groups. This
observation is in line with a recent study that has ana-
lysed the effects of a longitudinal stab injury of the lum-
bar spinal cord region of the same pre-symptomatic
animal model of ALS utilised in our study [41]. In this
experimental paradigm of more invasive spinal cord
injury, the level of host glial activation and the motor
cell numbers at the site of the lesion in a 2-week post-
injury period were not significantly different in the
injured G93A-SOD1 rats compared to the injured WT
littermates [41]. Our study demonstrates that the size of
the anterior horns motor cells in the G93A-SOD1 ani-
mals after compression SCI is significantly reduced
when compared to the WT motor cell population. Pre-
vious studies on animal models of ALS have also shown
a loss of the largest spinal motor neurons with the dis-
ease progression [42]. Various attempts to clarify
whether the late stage loss of large motor neurones is
due to a higher vulnerability of these neurones, which
may die or atrophy earlier than the small ones or
whether motor cells never reach their maximal size
before disease onset have not come to any conclusion
[43]. It is also not known whether the loss or the atro-
phy of large motor neurons is the main determinant of
the functional decline and ultimately of the loss of
motor units observed in the overt phase of the disease.
Clearly, the same type of uncertainties may apply to the
interpretation of our results. The presence of smaller
motor neurones in the G93A-SOD1 spinal cord one
week after compression injury may play a part in the
poor locomotor performances observed in the G93A-
SOD1 rats compared to their WT littermates under to
the same experimental conditions. The overall molecular
changes we have observed in the G93-SOD1 spinal cord
in the post-injury phase may also be responsible of the
poor functional recovery described in the G93-SOD1
rats.
Similarly to a number of published investigations, our
study has used WT littermates as control for the
human G93A-SOD1 rats, in order to ensure the maxi-
mum level of genetic homogeneity between the groups
of animals. This choice is of particular importance
when studying changes at a genetic level [6,36,41,44-48].
Previous studies have shown that the human G93A-
SOD1 transgene does not affect the endogenous rat
SOD1 protein levels [49]. However, it has also been
shown that the total SOD1 activity in the G93A-SOD1
rats is increased to 200-300% of the control level, as the
result of the combined endogenous SOD1 activity of
the rat and of the added mutant G93A-SOD1 activity
[49]. This observation is clearly important in the inter-
pretation of our results. In future studies, it will be use-
ful to include rats with elevated non-mutant SOD1
activity as an extra control group, in order to normalise
whatever experimental approach to comparable levels of
SOD1 activity [50].
Conclusions
Our study demonstrates a higher level of functional
impairment in the pre-symptomatic G93A-SOD1 rats
compared to their control WT littermates after mechan-
ical injury of the spinal cord, in the acute 1-week
post-injury phase. Comparative gene ontological analysis
indicates that the molecular response to a mild com-
pression SCI or to a simple surgical stress in pre-symp-
tomatic G93A-SOD1 rats genetically-modified to
develop ALS is distinctively different to that seen in
control WT littermates. The response to SCI in the
G93A-SOD1 spinal cord seems to replicate some of the
most crucial gene expression changes described in the
affected tissues during the natural development of ALS
and to demonstrate the same changes in the morphol-
ogy of the motor cell population observed in spinal cord
from individuals and animal models of the disease in an
advanced stage. The sustained recovery after injury
observed in WT rats may be driven, at a molecular
level, by a lower level of pro-apoptotic activity coupled
with the significant over-expression of factors involved
in transcription, angiogenesis, lipid transport and cell
adhesion. The results presented here contribute to the
understanding of how the genetic background affects
the ability of nervous tissues to withstand a mechanical
trauma, showing how a G93A-SOD1 gene mutation cre-
ates a milieu of gene expression changes which has an
unfavourable effect on functional recovery following a
mild compression injury to the spinal cord.
Methods
Animals
A breeding project was initiated at Taconic USA (Taco-
nic Inc., US), using 5 transgenic Sprague Dawley rats
expressing the G93A SOD1 gene mutation and 5 wild-
type (WT) littermates as breeding pairs, as previously
reported [6]. The G93A-SOD1 breeders were replaced
on a monthly basis before any sign of disease onset. An
average of 6 pups for each breeding pair were obtained
and stored in separate cages. Only female pups were
retained for further analysis and tail samples were taken
for genotyping. Only female rats have been used to
ensure consistence in rat gender with other studies of
spinal cord injury (SCI) [6,19]. Since SCI requires manual
emptying of bladder to prevent urinary tract infections,
we have chosen female animals because their bladders
are relatively easier to empty compared to male bladders.
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A total of 40 heterozygous rats carrying the G93A-SOD1
gene mutation and 40 Wild type (WT) littermates have
been shipped to our laboratories at the age of 6 weeks
and housed in specific pathogen-free animal facilities at a
room temperature of 21°C (under a 12 h light-dark
cycle). All animal procedures were conducted according
to the Animals (Scientific Procedures) Act 1986 as
approved by the United Kingdom Home Office. The
G93A-SOD1 transgenic rat model of ALS is known to
develop initial signs of motor impairment with either
hindlimb or forelimb distribution, at approximately
17 weeks of age, and to progress to end-stage disease in
approximately 1 or 2 weeks from disease onset [6]. We
have chosen the G93A-SOD1 rat rather than the more
widely used G93A-SOD1 mouse because of the need to
operate with an animal more suitable to well-established
experimental procedures for spinal cord injury.
Laminectomy and spinal cord compression
Compression SCI was performed on 27 pre-symptomatic
G93A-SOD1 transgenic female rats at 10 weeks of age,
an early pre-symptomatic stage for these rodent models
of ALS. Compression SCI was also performed on 27 WT
female age-matched littermates for reference as pre-
viously reported [6]. 10 WT and 10 G93A-SOD1 female
rats were subjected only to laminectomy, at 10 weeks of
age. Surgical procedures were performed as previously
described [29,6,19,30]. Following anaesthesia with a mix-
ture of isoflurane (2.5%), oxygen and nitrous oxide (1:1
ratio) at a flow rate of 750–1000 mL min, the skin and
muscle surrounding the vertebral column (T10-L1) were
incised and a laminectomy was performed at T12 level
without damaging the dura. The compression injury was
performed by statically applying a 35g weight for 5 min,
on a platform (area 2 mm × 5 mm), resting on the dura
of the exposed spinal segment. Manual bladder expres-
sion after surgery was performed twice daily. As pre-
viously reported [6], rats were sacrificed by asphyxiation
with carbon dioxide after surgery at the following time
points: 5 WT and 5 G93A-SOD1 rats at 30 minutes after
compression SCI, 5 WT and 5 G93A-SOD1 rats at
4 hours after compression SCI, 4 WT and 4 G93A-SOD1
rats at 24 hours after compression SCI, 5 WT and 5
G93A-SOD1 rats at 7 days after compression SCI, 3 WT
and 3 G93A-SOD1 rats at 30 minutes after laminectomy,
3 WT and 3 G93A-SOD1 rats at 4 hours after laminect-
omy. In addition, 5 naïve G93A-SOD1 rats and 5 naïve
WT littermates were also sacrificed at 10 weeks of age.
Naïve spinal cord tissues from WT and G93A-SOD1 ani-
mals were used as controls in the differential gene
expression analysis described below. Spinal cord samples
including the injury site and the adjacent segments (5
mm rostral and caudal to the lesion epicenter), were
dissected after sacrifice, submerged into 2-methylbutane
and subsequently frozen in liquid nitrogen.
Locomotor analysis after compression SCI
Following compression SCI, the level of functional
recovery in G93A-SOD1 and WT female rats was evalu-
ated initially at 4 hours, and then daily for a week using
the BBB locomotor scoring system [20,51,52]. The eva-
luation of the locomotor function in 24 10-week old
WT rats after mild compression SCI in a 7-day post-
injury time window has previously been reported [6].
The BBB scores for each animal was determined at the
chosen time points by two independent blinded obser-
vers and the mean BBB score per group was calculated.
All G93A-SOD1 and WT rats have been independently
scored using the BBB locomotor functional analysis
prior to compression SCI in order to demonstrate
similar baseline performances.
Bead-array gene expression analysis
Large-scale gene expression analysis of the spinal cord
samples harvested from the 54 animals after mild com-
pression SCI (epicenters of compression) or laminectomy
was performed using the Illumina ratRef-12 v1.0 expres-
sion Beadchip (Illumina, San Diego, USA; GEO GPL6101).
This Bead-chip contains 12 genome-scale gene expression
microarrays (22,523 probes per array). RNA was extracted
from the spinal cord samples obtained from injured and
uninjured rats, and from sham operated animals subjected
to laminectomy, using the SV total RNA isolation system
(Promega, UK). RNA quantification was performed using
a Nanodrop ND-1000 spectrophotometer and quality was
checked using the Agilent bioanalyser system (Agilent).
For the purpose of our gene expression analysis, we have
pooled the RNA samples obtained from the injury epicen-
ters that have been dissected from rats of the same genetic
type and sacrificed at the same post-injury time-point. We
have obtained a total of 14 RNA-pools (4 pools containing
RNAs from G93A-SOD1 cords extracted at the 30 min.
(n:5), 4 hours (n:5), 24 hours (n:4) and 7 days (n:5) time
points after compression SCI respectively, 2 pools contain-
ing RNAs from G93A-SOD1 spinal cords extracted at the
30 min. (n:4) and the 4 hours (n:4) time points after lami-
nectomy, 2 pools containing RNAs from WT spinal cords
extracted at the 30 min. (n:4) and at the 4 hours (n:4) time
points after laminectomy, 4 pools containing RNAs from
WT cords extracted at the 30 min (n:5), 4 hours (n:5), 24
hours (n:4) and 7 days (n:5) time points after compression
SCI respectively; finally 1 pool containing G93A-SOD1
(n:5) and 1 pool containing WT (n:5) spinal cords
extracted from 10 week-old naive animals (used as refer-
ences in the gene expression analysis) of which we have
tested the gene expression profile. The pool of RNA
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samples from G93A-SOD1 spinal cords harvested at
30 minutes from compression injury was also used for a
technical replica experiment.
cRNA labeling was performed with 750 ng of pooled
RNA, using the Ambion Total Prep kit. cRNA purity
and labelling was checked using the Nanodrop and Agi-
lent bioanalyser. 500 ng from each of the 14 RNA pools
were hybridised simultaneously to 16 arrays (including 2
arrays for the technical replica experiment) contained in
2 RatRef-12 Expression BeadChips, as per Illumina pro-
tocol (Illumina, San Diego, USA).
Differential gene expression and correlation analysis
the Bead-chip output files were analyzed using the
BeadStudio-3 Software (Illumina, San Diego, USA) as
previously reported [6]. The expression level of each
probe was defined by a value of intensity and by a p-
value detection, which measures the probability of sig-
nal recovery without specific probe target hybridiza-
tion. Genes differentially expressed at the selected
time-points after compression SCI and laminectomy
were identified by comparing G93A-SOD1 and WT
spinal cord tissues with genetically-matched naïve tis-
sues. We have also performed a differential gene
expression analysis with a direct comparison of G93A-
SOD1 and WT tissues at the selected time-points after
injury. This approach allows the identification of gene
candidates presenting different expression behaviours
in the two tissues in study, but does not indicate the
nature of the expression change in each spinal cord
type compared to genetically-matched un-injured
(naïve) tissue. Therefore, genetically-matched naïve tis-
sues were used as a reference for data interpretation.
The gene expression changes identified in spinal cord
from the naive (10-week old) G93A-SOD1 rats (using
the spinal cord tissue from age-matched WT litter-
mates as reference), have been taken into account for
the interpretation of the gene expression results
obtained from injured spinal cord samples and from
spinal cords dissected from animals subjected to
laminectomy.
Stringent selection criteria (Bead Studio-3), including
a rank invariant normalization algorithm, an Illumina
Custom error model (to compute non-specific cross-
hybridization and the effects of variation arising from
non-biological factors) and a false discovery rate (FDR)
were used in the differential gene expression analysis
as previously described [6]. To evaluate the reproduci-
bility of our results, we have performed a correlation
test (BeadStudio scatter plot analysis) between the
gene expression profiles generated from the G93A-
SOD1 and the WT spinal cord tissues, with those
obtained from naive control tissues of the correspond-
ing genetic type. We have also extracted from the
array data, the intensity values of detection at the
various experimental time points after compression
SCI for Nfh and for other gene candidates involved in
retinoid signaling (ReS).
Ontology analysis of the gene expression data
We have used High-Throughput GoMiner as previously
reported [6,21] for an ontological analysis of the gene
expression changes in spinal cord tissue from WT and
G93A-SOD1 animals after compression injury and lami-
nectomy. High-Throughput GoMiner provides an inte-
grated biological interpretation of multiple gene
expression datasets. The program identifies those gene
categories within the Gene Ontology (GO) database
which present a significant level of enrichment of the
differentially regulated genes under investigation. We
have submitted to High-Throughput GoMiner 9 text files
reporting “changed genes” found to be differentially
regulated after compression SCI in G93A-SOD1 and in
WT spinal cord pools extracted at 30 minutes, 4 hours,
24 hours and 7 days from injury (tissues from geneti-
cally-matched naïve rats sacrificed at the same time
points were used as references) and in the 10-week old
G93A-SOD1 uninjured spinal cord pool compared to a
WT naïve spinal cord pool from age-matched litter-
mates. A set of four text files containing “changed
genes” identified in the G93A-SOD1 and in the WT
spinal cord pools at 30 minutes and 4 hours after lami-
nectomy were submitted separately, along with a list of
all the probes contained in the Illumina rat Beadchip.
As previously reported, a flat +1 or -1 binary code was
used to express up-regulation or down-regulation of the
genes included in the 13 text files [6]. GO categories
were identified and sorted according to a false discovery
rate (FDR; threshold of 0.05) and to the level of enrich-
ment of “changed genes”. A multiple comparisons cor-
rection was used to eliminate GO categories that
appeared significantly represented simply by chance.
The FDR value for a specific GO category identified in a
text file was automatically computed for all the remain-
ing text files, allowing an estimation of the relative
importance of each gene category across all time points
and experimental groups. Visual integration of the
results was obtained using clustered image maps and an
Excel drawing platform and the results have been dis-
played as heat maps as previously reported [6].
cDNA synthesis and real time RT-PCR
RNA from the epicenters of injury in the thoracic spinal
cord samples obtained from rats of the same genetic
type sacrificed at the same time point from compression
injury were pooled together (5 samples for each pool)
and used for cDNA synthesis using the ImProm-II
Reverse Transcription System (Promega, Madison, Wis-
consin). 2.5 μg of total RNA from each pool was treated
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with RNase-free DNase and then heated to 75°C for
10 minutes for DNase inactivation and RNA denatura-
tion. Reverse-transcription was carried out with 1 μl
random primers (150 ng/μl) and with 1 μg of RNA. A
mixture of 4 μl 5 × reaction buffer, 2 μl of 25 mM
MgCl2, 1 μl of 10 mM dNTP mix, 0.5 μl recombinant
RNasin ribonuclease inhibitor (40 U/μl) and 1 μl
ImProm-II™ Reverse Transcriptase (Promega, Madison,
Wisconsin) was added to each sample and double dis-
tilled H2O up to a total of 15 μl. The samples were
incubated at 25°C for 5 minutes, then at 55°C for 60
minutes and finally at 70°C for 15 minutes. Negative
control had no ImProm-II™ Reverse Transcriptase.
Real time RT-PCR
Real time RT-PCR was performed with SYBR Green
(ABgene, Epsom, UK), using a Rotor-Gene 3000
system (Corbett Research, Sydney, Australia). Primers
(Invitrogen, Paisley, UK) were designed and used in the
amplification process for the following genes: the neuro-
filament heavy chain (Nfh F: AGA GGC AGA AGA
GGG AGG AG - Nfh R: TGA CCT CAG CTG GTG
ACT TG); the microtubule-associated protein 1B
(Map1b 1 F: CCT GCC AAA GAA CTT GAA GC -
Map1b 1 R: CCT TTG CTG ACT TCC GTC TC);
S100A8 protein (S100A8 1 F: GGC AAC TGA ACT
GGA GAA GG - S100A8 1 R: ACC CTT ATC ACC
AAC GCA AG); nucleotide-gated potassium channel 2
(Hcn2 F: CTG CGT GAG GAG ATT GTG AA - Hcn2
R: TTT GAG CTT TGT CAG CAT GG); the tissue
inhibitor of metalloproteinase 2 (Timp2 1 F: CAA GTT
CTT TGC CTG CAT CA - Timp2 1 R: TCC AGG
AAG GGA TGT CAA AG). Amplification conditions
were as follows: 95°C for 15 min, followed by 40 cycles
of 95°C for 10 s; 60°C for 15 s; 72°C for 20 s. Each real
time PCR experiment was performed in triplicate, using
cDNA templates originated from 2.5 μg of RNA. The
expression of the test genes was evaluated following
normalization to the level of ribosomal 18 S contained
in each sample. Due to the 18 S abundance in the tis-
sues, the 18 S cDNAs were diluted 100-fold before RNA
measurement. A standard curve was generated by real-
time RT-PCR analysis from triplicates of five ten-fold
dilutions of cDNA generated from 1 ng of spleen RNA.
Real time PCR runs showing mRNA expression signals
for the negative control samples were discarded and
new cDNA was generated for a re-run.
Immunohistochemistry
The protein expression of the neurofilament heavy chain
(Nfh) and of synaptophysin (SYN) in spinal cord after
compression SCI has been studied by immunohisto-
chemistry. Spinal cord samples immediately caudal to
the site of compression SCI were harvested from 3 WT
and 3 G93A-SOD1 rats at 30 min, 4 h, 24 h and 7 days
after compression SCI and from naïve 10-week old rats,
for immunostaining. Tissue samples were frozen in
liquid nitrogen and stored at -80°C. Fresh frozen tissues
were mounted on tissue holders and 15 μm sections
were cut on a cryostat. Slides with fresh frozen tissue
were post-fixed with 100% ethanol for 10 minutes, fol-
lowed by 3 washes for 10 minutes in phosphate buffered
saline (PBS). Endogenous peroxidases were inhibited by
treating slides with 0.3% H2O2 for 10 minutes. After 3 ×
PBS washes for 10 minutes, non-specific antibody sites
were blocked with 10% donkey serum in 0.3% triton/
0.1% sodium azide PBS solution for 2 h. Primary anti-
mouse antibodies for Nfh (clone N52, 1:20,000, Sigma)
and SYN (1:5,000, Sigma) diluted in 0.3% triton/0.1%
sodium azide and PBS solution were applied for 24 h
followed by biotinylated secondary anti-mouse (for Nfh)
and anti-rabbit (for SYN) antibodies at dilution 1:800 in
0.3% triton/0.1% sodium azide PBS solution for 1 h.
Vectastain Elite ABC Kit (Vector laboratories) was sub-
sequently added for 30 minutes to form an avidin-biotin
complex. The reaction was visualised after incubation
with 3, 3’-diaminobenzidine (DAB, Sigma) and sections
were mounted in xylene-based DPX mounting medium.
The Nfh antibody (clone N52) has been previously used
in our lab and published by other authors. It has been
extensively characterised by Western blot analysis, tested
for cross-reaction with other neurofilaments, and it has
become an established marker for myelinated DRG neu-
rons [53,51,52,27]. The synaptophysin antibody (Sigma
S5768; mouse synaptosome preparation from rat retina
-1:500 dilution) has also been extensively tested and its
immunoreactivity has been quantified using the same
method previously reported [54].
Histopathological assessment of the WT and G93A-
SOD1 rat spinal cord after mild compression injury
using luxol fast blue staining and inflammatory markers
was performed as previously described [26-29,54-56].
We have used frozen 20 μm transverse spinal cord sec-
tions caudal to the compression site from animals sacri-
ficed 7 days after compression injury. Sections were
dehydrated in a graded ethanol series (5 min each) and
then incubated overnight in 0.1% luxol fast blue solution
at 37°C. Differentiation of slides was carried out with
0.05% lithium carbonate to distinguish white and gray
matter staining and then dehydrated in a graded ethanol
series. Slides were dipped in xylene and mounted in
DPX mounting medium. Slides with fresh frozen tissue
for immunohistochemistry were post-fixed with 4% par-
aformaldehyde for 1 h, followed by 3 washes for 5 min-
utes in PBS. Immunofluorescent staining with mouse
anti- ED1 (1:400, Chemicon), mouse anti-OX42 (1:200,
Serotec) and rabbit anti-GFAP (1:1000, Dako) was car-
ried out overnight at room temperature. After 3 × PBS
washes for 5 minutes, secondary donkey anti-mouse
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AlexaFluor 488 or goat anti-rabbit AlexaFluor 568
(1:1000, Invitrogen) was applied for 3 h at room tem-
perature. Nissl staining of motor neurones was carried
out using Neurotrace fluorescent Nissl stain (1:100, Invi-
trogen) according to manufacturer’s instruction. After a
further 3 × PBS washes for 5 minutes, sections were
mounted in Vectashield mounting medium containing
with or without DAPI (Vector Labs).
A summary of the specifications of the antibodies used
for the immunohistochemical analyses is presented in
Table 1.
Western blotting
A spinal cord segment rostral to the compression site was
freshly collected from 3 G93A-SOD1 and from 3 WT age-
matched rats 24 hours from compression SCI and stored at
-80°C until processed. The spinal cord tissues were pro-
cessed for Western blot as previously described [57]. Briefly,
spinal cord tissues were homogenized in 1 ml of ice-cold
lysis buffer (20 mM HEPES pH 7.4, 100 nM NaCl, 100 mM
NaF, 1 mM Na3VO4, 5 mM EDTA, 1% Nonidet P-40 and 1
× protease inhibitor cocktail; Roche). The lysates were
rotated for 2 h at 4°C then centrifuged at 13,500 g for 15
min at 4°C. Total protein concentration was determined for
the collected supernatant using a bicinchoninic acid protein
assay kit (Pierce). Fifteen micrograms of total protein were
electrophoresed on 12% acrylamide gel before transfer onto
Hybond P membranes (Amersham) and incubated over-
night at 4°C with mouse anti-NF200 (clone N52, 1:1,500)
and mouse anti-b-actin (1:5,000). Although both antibodies
were raised in mouse, the difference in molecular size
(NF200 is 200 KDa and b-actin is 42 KDa) allows for simul-
taneous probing on the same blot. Visualisation was per-
formed using the secondary antibody goat anti-mouse
IRdye-680CW (LI-COR Biosciences). Fluorescent blot was
imaged on the Odyssey Infrared Imaging System (LI-COR
Biosciences). The bands were quantified using AxioVision
4.6 program and the results were expressed as a ratio with
its corresponding internal control b-actin.
Histological analysis
The intensity of Nfh staining in motor neurons (10 –
15 per section) was measured at 20 × magnification
using Scion Image (release alpha 4.0.3.2). The average
intensity of Nfh staining (gray level) of motor neurons
was measured and the average background staining inten-
sity was subtracted. Analysis of SYN-immunoreactive
synaptic boutons was performed at 40× magnification.
The average intensity (gray levels) of SYN-stained nerve
terminals and subtracted the average staining intensity of
the background was determined. The analysis of ED1,
Table 1 Main characteristics of the antibodies used for the experiments detailed in the manuscript
Manufacturer Product &
Lot No.
Host
species
Immunogen Dilution used
Primary antibodies
Neurofilament (clone
N52)
Sigma N0142 &
65K4804
mouse C-terminal segment of enzymatically
dephosphorylated pig neurofilament 200
1:20,000 using
immunoperoxidase staining
1:1500 using Western blotting
Synaptophysin (clone
SVP-38)
Sigma S5768 &
90K4844
mouse Rat retina synaptosome 1:5000 using immunoperoxidase
staining
Rat CD68-
macrophages/
monocytes (clone
ED-1)
Chemicon MAB1435 &
0606032963
mouse A single chain glycoprotein of 90-100 KDa that is
expressed on the lysosomal membrane of myeloid
cells
1:400 using immunofluorescent
staining
Rat CD11b; RPE
(clone OX-42)
Serotec MCA275EL
& 0105
mouse Rat peritoneal macrophages 1:200 using immunofluorescent
staining
Glial fibrillary acid
protein (clone SVP-
38)
Dako Z0334 &
00045904
rabbit Cow spinal cord 1:1000 using Immunofluorescent
staining
b-actin (clone AC-15) Sigma A1978 &
118K4827
mouse Fusion of mouse myeloma cells and splenocytes
immunized with a synthetic b-cytoplasmic actin N-
terminal peptide
1:5000 using Western blotting
NeuroTrace
(fluorescent Nissl
stain)
Molecular
Probes
N21480 &
4971-21
- - 1:100 according to
manufacturer’s instruction
Secondary antibodies
Alexa Fluor 488 Invitrogen A21202 &
536050
donkey Anti-mouse IgG (H+L) 1:1000 using immunofluorescent
staining
Alexa Fluor 568 Invitrogen A10042 &
538952
donkey Anti-rabbit IgG (H+L) 1:1000 using immunofluorescent
staining
Alexa Fluor 680 Invitrogen A21057 &
65E2-1
goat Anti-mouse IgG (H+L) 1:15,000 using Western blotting
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OX42 and GFAP immunostaining was determined simi-
larly to previously described [28,54]. Spinal cord sections
were captured with the same intensity and settings using
the Zeiss Axioplan 2 fluorescence microscope. The num-
ber of positively stained ED1, OX42 and GFAP cells was
determined at 20 × magnification in a 1 × 104 μm2 box
place over the ventral horn using the Axiovision 4.6
program.
To determine the amount of spared white matter cau-
dal to the injury, the area of white matter positively
stained with luxol fast blue was measured using the
Axiovision 4.6 program. All analyses for immunohisto-
chemical staining were performed in the ventral spinal
cord of 6-8 non-adjacent sections of a spinal cord seg-
ment caudal to the epicenter of injury from 3 WT and
3 G93A-SOD1 animals.
Motor neurone analysis: numbers and cell size
The count of motor neurones and the analysis of the
motor neurones cell size was carried out as previously
described [57]. Cell area of Nissl labelled motor neu-
rones with visible DAPI positive nuclei in the spinal
cord ventral horn was acquired using the AxioVision
V4.6 program. Size and frequency distributions of motor
neurones were determined for each rat and a mean dis-
tribution calculated for both G93A-SOD1 and WT rats.
At least six spinal cord sections were analysed and
quantified per rat (n = 3-4 per group). Statistical analysis
was carried out using a two-sample Kolmogorov-Smir-
nov test, performed against a significant threshold of
0.05 to correct for multiple testing.
Statistical analysis
The data were presented as means and standard errors
of the means (SEM). The behavioural data were
analysed with two-way ANOVA followed by Tukey’s
post-hoc test. Histological and Western blot data were
analysed with Student’s t-test. P < 0.05 was considered
statistically significant.
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